Understanding the NSW Medicines, Poisons and Therapeutic Goods Act and Regulation – Key changes and implications for doctors
Webinar 7 May, 7:30 PM - 8:30 PM (AEST)
This webinar will provide you with an overview of the new legislative framework for medicines, poisons, and therapeutic goods in NSW. Commencing late 2025, the Medicines, Poisons and Therapeutic Goods Act 2022 and its Regulation will replace the current framework, introducing updated provisions for prescribing, supplying, dispensing, administering, storing, labelling, and record-keeping of scheduled medicines.
Find out what is and isn’t changing under the new legislation and the impact to a GP’s practice to prescribe, supply, and administer medicines. You will be informed on the medicines that require approval from NSW Health, the requirements under the new registration process for providing treatment under the NSW Opioid Treatment Program (OTP), and compliance requirements under the new framework.
Don’t miss this opportunity to stay ahead of regulatory changes and ensure compliance in your practice.
Learning outcomes
- Understand the key changes and compliance requirements in the Medicines, Poisons, and Therapeutic Goods Act 2022 and its Regulation
- Identify the medicines that require approval, or are exempt from approval, and understand the process for applying for an approval
- Understand your registration obligations for the treatment of patients on the Opioid Treatment Program (OTP)
- Recognise your obligations under the new regulatory framework, including supply and prescription requirements, storage and record-keeping
Educational Activities
1.0
hours
Facilitator
Dr Natasha Feingold
General Practitioner
Dr Natasha Feingold is a GP from Sydney who has recently moved to the Gold
Coast, QLD and works for a specialised women’s health clinic where she has a speciality interest in chronic disease management.
She is committed to the quality medical education of junior doctors and worked for many years as a lecturer at the
University of Notre Dame School of Medicine. Additionally, Dr Feingold is an examiner for RACGP fellowship exams to ensure the next generation of GPs are providing a high standard of care. She also previously held a position on the RACGP faculty for NSW/ACT where she advocated for recently fellowed GPs and
organised wellbeing conferences for doctors and their families. Finally, Dr Feingold is also a wife and mother of two young boys which helps keeps her balanced outside of her clinic.
Speakers
Monique Reyes
Principal Officer - Poisons and Therapeutic Goods Act Review
As the Principal Officer at the NSW Ministry of Health, Monique managed the review of the Poisons and Therapeutic Goods Act, which led to the passing in NSW Parliament of the Medicines, Poisons and Therapeutic Goods Act 2022. A pharmacist with a Master of Health Law, she has over 30 years’ experience across the private and public sectors, including 14 years in government. Monique is dedicated to achieving the paramount objective of protecting public health and safety. Her focus is on developing clear and enforceable laws from informed and considered policy, in consultation with health practitioners and other stakeholders
David Ng
Chief Pharmacist and Director, Pharmaceutical Services Unit, NSW Ministry of Health
David Ng is currently the Chief Pharmacist and Director, Pharmaceutical Services with the NSW Ministry of Health supporting the regulatory frameworks and guidance relating to medicines and poisons, and the quality and safety for the use of medicines. Prior to his current role, David was the Director of Pharmacy for Western Sydney Local Health District at Westmead Hospital, a major tertiary hospital in Sydney, Australia - servicing the largest growing population in one of the largest health districts in Australia.